-
ASSOCIATION BETWEEN EORTC QLQ-C30 SUMMARY SCORE AND GLOBAL HEALTH STATUS IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A PROSPECTIVE LONGITUDINAL STUDY
Aug 11, 2026, 17:16 PM -
HOW AVAILABLE IS INFORMATION ON HTAR-RELATED PROCESS ADAPTATION AMONG THE 34 AUTHORITIES AND BODIES IN THE JCA SUBGROUP?
Aug 11, 2026, 17:16 PM -
WHEN TIME MATTERS: THE VALUE OF IN VITRO DIAGNOSTIC TESTING IN ONCOLOGY IN PORTUGAL
Aug 11, 2026, 17:16 PM -
MODIFYING THE NUMBER NEEDED TO SCREEN (NNS) TO ACCOUNT FOR THE PREVALENCE DIFFERENCE (PD) OF RISK FACTORS: A NOVEL APPROACH
Aug 11, 2026, 17:16 PM -
CLINICAL-ECONOMIC EVALUATION OF INTEGRATED STRATEGIES FOR SEVERE ASTHMA MANAGEMENT IN ITALY: A MULTIDIMENSIONAL PREDICTIVE APPROACH
Aug 11, 2026, 17:16 PM -
CLINICAL BURDEN AND INDIRECT COSTS ASSOCIATED WITH MORTALITY FROM HPV CANCERS: A FOCUS ON THE ITALIAN CONTEXT
Aug 11, 2026, 17:16 PM -
WHO IS RESPONSIBLE? MAPPING THE ACCOUNTABILITY GAP FOR AI USE IN MANUFACTURER DOSSIER SUBMISSIONS TO HTA BODIES0
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF MYASTHENIA GRAVIS: SOCIETAL COST-OF-ILLNESS ASSESSMENT IN FRANCE
Aug 11, 2026, 17:16 PM -
LESSONS FROM TEN YEARS OF MEDICAL DEVICE ECONOMIC EVALUATIONS IN FRANCE: A REVIEW OF CEESP EFFICIENCY OPINIONS
Aug 11, 2026, 17:16 PM -
PREPARING FOR JOINT CLINICAL ASSESSMENT: COMPARING HTA COMPARATORS, CLINICAL PRACTICE, AND REAL-WORLD FIRST-LINE NSCLC TREATMENT IN THE EU4 + UK
Aug 11, 2026, 17:16 PM -
DIPEPTIDYL PEPTIDASE-4 INHIBITOR-ASSOCIATED HYPERKALEMIA: A DISPROPORTIONALITY ANALYSIS IN THE FAERS DATABASE
Aug 11, 2026, 17:16 PM -
EFFICACY AND SAFETY OF FIRST-LINE TREATMENT STRATEGIES IN RAS/KRAS-MUTATED METASTATIC COLORECTAL CANCER: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
HOW MANY PICOS IS TOO MANY? QUANTIFYING THE EVIDENCE BURDEN OF THE EU JOINT CLINICAL ASSESSMENT
Aug 11, 2026, 17:16 PM -
GEOGRAPHIC ACCESS TO HEALTHCARE AMONG OLDER ADULTS: NATIONAL ESTIMATES OF TRAVEL BURDEN IN MEDICARE
Aug 11, 2026, 17:16 PM -
DEVELOPING AN EQ-5D-5L VALUE SET FOR QATAR
Aug 11, 2026, 17:16 PM -
THE CLINICAL IMPACT OF FORMULARY RESTRICTIONS: PHARMACY CLAIM DENIALS, DEMOGRAPHIC DISPARITIES, AND HOSPITALIZATION RATES FOLLOWING PRESCRIPTION ABANDONMENT
Aug 11, 2026, 17:16 PM -
REDUCING INFLUENZA BURDEN IN OLDER ALGERIANS: COST-EFFECTIVENESS ANALYSIS OF HIGH DOSE VS STANDARD DOSE INACTIVATED INFLUENZA VACCINE IN ADULTS AGED 75 AND OLDER
Aug 11, 2026, 17:16 PM -
HEALTH TECHNOLOGY ASSESSMENT OF OUT-LICENSED CHINESE-ORIGIN ONCOLOGY ASSETS: A DESCRIPTIVE CASE SERIES OF COMPLETED NICE APPRAISALS
Aug 11, 2026, 17:16 PM -
A SENTENCE-LEVEL ASSESSMENT FRAMEWORK FOR EVALUATING AI-GENERATED STUDY SUMMARIES AGAINST EXPERT-CURATED CLINICAL OVERVIEW
Aug 11, 2026, 17:16 PM -
A PROOF-OF-CONCEPT FRAMEWORK FOR ADAPTING EQ-5D-5L UTILITY ESTIMATES FOR HEALTH TECHNOLOGY ASSESSMENT IN MENA: AN ASTHMA CASE STUDY
Aug 11, 2026, 17:16 PM
